Hutchinson Cancer Center announced $710.5 million gift to support cancer and infectious disease research, ‘skin-on-chip’ technology
On Oct. 12, 2022, the Fred Hutchinson Cancer Center (FHCRC) announced the Bezos family had committed $710.5 million…
-
-
Mayo Clinic received $100 million gift from Fred C. and Katherine B. Andersen Foundation to expand proton beam therapy services
On Oct. 10, 2022, the Mayo Clinic announced that The Fred C. and Katherine B. Andersen Foundation of…
-
Pfizer and BioNTech’s Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine booster received Health Canada authorization for individuals 12 years of age and older
On Oct. 7, 2022, Pfizer and BioNTech announced that Health Canada had authorized COMIRNATY Original & Omicron BA.4/BA.5…
-
FDA Modernization Act reauthorized the Prescription Drug User Fee Act of 2017
On Sept. 22, 2022, the President signed into law the U.S. Food and Drug Administration (FDA) User Fee…
-
Biotechnology | Diagnostics | Disease | Genomics | NIH | Therapeutics
NIH established initiative to systematically investigate and establish function of every human gene
On Sept. 27, 2022, the National Institutes of Health (NIH) announced it had launched a program to better…
-
Pfizer to supply global fund up to 6 million PAXLOVID treatment courses for low-and-middle-income countries
On Supt. 22, 2022, Pfizer announced an agreement to supply up to six million treatment courses of its…
-
Biotechnology | Cartoons - Original | CRISPR | Disease | Genomics | Medicine | Nanotechnology | Neurology | Non-Profit Research | Oncology | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine
U.S. Biotechnology & Biomanufacturing Initiative
On Sept. 14, 2022, The U.S. Biotech Initiative was announced detailing new investments and resources to advance the…
-
Fred Hutchinson Cancer Center received $78 million gift to support precision oncology
On Sept. 8, 2022, the Fred Hutchinson Cancer Center (FHCRC) announced that Stuart and Molly Sloan had pledged…
-
Biotechnology | Cosmetic | FDA | Therapeutics
FDA Approved Daxxify, a New Anti-Wrinkle Drug
On Sept. 7, 2022, the U.S. Food and Drug Administration (FDA) announced it had approved Revance Therapeutics’ DAXXIFY…
-
Biotechnology | Diagnostics | Disease | Medical Device | Medicine | Non-Profit Research | Therapeutics
University of Victoria BioInnovation Hub to enhance collaboration in BC’s life sciences sector
On Aug. 31, 2022, a new front-door to the University of Victoria opened to advance health and life…
-
$838 Million neurosciences center broke ground in Connecticut
On Aug. 31, 2022, the Yale New Haven Hospital broke ground on the $838 million, 505,000 square foot…
-
Pfizer and BioNTech completed submission to EMA for Omicron BA.4/BA.5 adapted bivalent vaccine
On Aug. 26, 2022, Pfizer and BioNTech announced they had completed a submission to the European Medicines Agency…
-
First gene therapy for adults with severe hemophilia A, BioMarin’s ROCTAVIAN, approved by EC
On Aug. 24, 2022, BioMarin Pharmaceutical announced that the European Commission (EC) has granted conditional marketing authorization (CMA)…
-
FDA approved first cell Based gene therapy to treat adult and pediatric patients with Beta-thalassemia
On Aug. 17, 2022, the U.S. Food and Drug Administration announced it had approved Zynteglo (betibeglogene autotemcel), the…
-
Biotechnology | FDA | Infectious Disease | NIH | Therapeutics | Vaccine
U.S. Department of Health and Human Services made more vaccine doses available to support Mpox response
On Aug. 15, 2022, the U.S. Department of Health and Human Services announced that was making up to…
-
Roche announced U.S. FDA approval of Xofluza to treat influenza in children aged five years and older
On Aug. 11, 2022, Roche announced that the U.S. Food and Drug Administration (FDA) had approved a supplemental…
-
Biotechnology | Diagnostics | Disease | FDA | Oncology | Radiology | Therapeutics | Women's Health
FDA approved first targeted therapy for HER2-low breast cancer
On Aug. 5, 2022, the U.S. Food and Drug Administration (FDA) approved Daiichi Sankyo’s Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV…
-
Biotechnology | COVID-19 | NIH | Therapeutics | Vaccine
HHS announced 66 million doses of Moderna’s variant-specific COVID-19 vaccine booster for potential use in Fall and Winter 2022
On Jul. 29, 2022, the U.S. Department of Health and Human Services (HHS), in collaboration with the U.S….
-
AlphaFold revealed the structure of the protein universe
On Jul. 28, 2022, AlphaFold, in partnership with EMBL’s European Bioinformatics Institute (EMBL-EBI), announced they we’re releasing predicted…
-
Biotechnology | CDC | Disease | Environmental | Therapeutics
Bacteria that causes rare disease Melioidosis discovered in U.S. environmental samples
On Jul. 27, 2022, the Centers for Disease Control and Prevention (CDC) announced that it had identified for…
-
Patient with HIV achieved remission following stem cell transplant
On Jul. 27, 2022, City of Hope announced that a 66-year-old man who was diagnosed with HIV in…
-
Biotechnology | Cartoons - Original | COVID-19 | Diagnostics | Medicine | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine
COVID-19 Vacations Redux
COVID-19 Vacations Redux iIlustrates once again the pits and perils vacation travelers face as they begin their Summer…
-
CHMP adopted positive opinion recommending Veklury (Remdesivir) receive full Marketing Authorization for teatment of patients with COVID-19
On Jul. 22, 2022, Gilead Sciences announced that the Committee for Medicinal Products for Human Use (CHMP) of…
-
Australia TGA granted provisional approval for Moderna’s COVID-19 vaccine in children aged six months to five years
On Jul. 19, 2022, Moderna said that Australia’s drug regulator Therapeutic Goods Administration (TGA) has provisionally approved its…
-
Gilead Sciences signed joint procurement agreement with the European Commission for Veklury (Remdesivir)
On Jul. 19, 2022, Gilead Sciences and the European Commission announced a new joint procurement agreement (JPA) that…
-
COVID-19 | Infectious Disease | NIH | Therapeutics | Vaccine
Vaccine-induced immune response to Omicron wanes substantially over time
On Jul. 19, 2022, the National Institutes of Health (NIH) announced that although COVID-19 booster vaccinations in adults…
-
Pfizer and BioNTech submitted a variation to EMA for vaccination of children ages 6 months to less than 5 Years with COMIRNATY
On Jul. 8, 2022, Pfizer and BioNTech announced that the companies had submitted a variation to the European…
-
Ghana reported first-ever suspected cases of Marburg virus disease
On Jul. 7, 2022, Ghana has announced the preliminary finding of two cases of Marburg virus disease and…
-
Novavax Nuvaxovid COVID-19 vaccine conditionally authorized in EU for adolescents aged 12 through 17
On Jul. 5, 2022, Novavax announced that the European Commission (EC) had approved the expanded conditional marketing authorization…
-
COVID-19 vaccination activates antibodies targeting parts of virus spike protein shared between coronaviruses
On Jul. 5, 2022, Tgen and Northern Arizona University announced that a research team found that the vaccine…
